Home | The logistics of delivering a global vaccine
In this issue
Contents
Mimotopes
SHL Medical
Briefing
Industry news
The pharma industry briefing
Covid-19 executive briefing by GlobalData
Solvias Company Insight
Solvias
HOF Sonderanlagenbau Company Insight
HOF Sonderanlagenbau
Swiftpak
Comment
Long HCC pipeline marks change for a previously stagnant market
Pfizer and BioNTech’s Covid-19 vaccine candidate shows 90% efficacy
Blockchain-enabled hospital can provide real-world data
The increasing influence of industry sponsors along the pandemic timeline
Digitalisation in pharmaceutical manufacturing
VEGA Australia
Kugelmeiers
Unither Pharmaceuticals
In Depth
Special delivery: the logistics of curing Covid-19
Will there ever be an HIV vaccine?
Predicting Covid-19 vaccine approvals with Opyl
Unequal access: understanding cancer treatment disparity in Europe
‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?
Q&A: investing in innovative biotechs with Novo Ventures
Gold standard: why are Phase III trials so critical?
Brewprint: using yeast to make plant-based drugs
Air France
Zenatek Company Insight
In Data
Inside the deal
Deals analysis
The pharma industry key list
Global markets and indices
Macro-economic indicators
Macro-economic indicators (page 2)
Events
Next issue
11/18/2020 00:00:00
Go to article:
Home | The logistics of delivering a global vaccine
Go to article:
In this issue
Go to article:
Contents
Go to article:
Mimotopes
Go to article:
SHL Medical
Go to article:
Briefing
Go to article:
Industry news
Go to article:
The pharma industry briefing
Go to article:
Covid-19 executive briefing by GlobalData
Go to article:
Solvias Company Insight
Go to article:
Solvias
Go to article:
HOF Sonderanlagenbau Company Insight
Go to article:
HOF Sonderanlagenbau
Go to article:
Swiftpak
Go to article:
Comment
Go to article:
Long HCC pipeline marks change for a previously stagnant market
Go to article:
Pfizer and BioNTech’s Covid-19 vaccine candidate shows 90% efficacy
Go to article:
Blockchain-enabled hospital can provide real-world data
Go to article:
The increasing influence of industry sponsors along the pandemic timeline
Go to article:
Digitalisation in pharmaceutical manufacturing
Go to article:
VEGA Australia
Go to article:
Kugelmeiers
Go to article:
Unither Pharmaceuticals
Go to article:
In Depth
Go to article:
Special delivery: the logistics of curing Covid-19
Go to article:
Will there ever be an HIV vaccine?
Go to article:
Predicting Covid-19 vaccine approvals with Opyl
Go to article:
Unequal access: understanding cancer treatment disparity in Europe
Go to article:
‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?
Go to article:
Q&A: investing in innovative biotechs with Novo Ventures
Go to article:
Gold standard: why are Phase III trials so critical?
Go to article:
Brewprint: using yeast to make plant-based drugs
Go to article:
Air France
Go to article:
Zenatek Company Insight
Go to article:
In Data
Go to article:
Inside the deal
Go to article:
Deals analysis
Go to article:
The pharma industry key list
Go to article:
Global markets and indices
Go to article:
Macro-economic indicators
Go to article:
Macro-economic indicators (page 2)
Go to article:
Events
Go to article:
Next issue